<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Medical Journal of the Islamic Republic Of Iran</title>
<title_fa>مجله پزشکی جمهوری اسلامی ایران</title_fa>
<short_title>Med J Islam Repub Iran</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mjiri.iums.ac.ir</web_url>
<journal_hbi_system_id>2</journal_hbi_system_id>
<journal_hbi_system_user>journal2</journal_hbi_system_user>
<journal_id_issn>1016-1430</journal_id_issn>
<journal_id_issn_online>2251-6840</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.18869/mjiri</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1379</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2000</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<volume>14</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>HLA-DRBI ALLELE FREQUENCY IN MYAS THENIA GRAVIS PATIENTS FROM SOUTHERN IRAN</title>
	<subject_fa>Immunology</subject_fa>
	<subject>Immunology</subject>
	<content_type_fa>Original Research</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>HLA-DRB1 allele frequencies of 28 myasthenia gravis (MG) patients, residents
of southern Iranian provinces, were studied using PCR-SSP method. The
control group consisted of 100 healthy individuals of the same ethnic group. The
allele HLA-DRB1 * 16 (RR= 2.04, p= 0.028) was found to be significantly increased
in MG patients compared to the control group, whereas HLADRB1
* 15(RR= 0.17 p= 0.043) and HLA-DRB1 *07 (p= 0.036) were found to be
significantly increased in the control group compared to the patients, and seem to
be negatively associated with the disease.
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Myasthenia gravis, HLA-DRBl, PCR-SSP</keyword>
	<start_page>223</start_page>
	<end_page>225</end_page>
	<web_url>http://mjiri.iums.ac.ir/browse.php?a_code=A-10-298-310&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>A</first_name>
	<middle_name></middle_name>
	<last_name>GHADERI</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>immunol@sums.ac.ir</email>
	<code>20031947532846004343</code>
	<orcid>20031947532846004343</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>From the Departments of Immunology and Neurology, Unit of Internal Medicine, Medical School, Shiraz University of Medical Sciences, Shiraz, I.R. Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>J</first_name>
	<middle_name></middle_name>
	<last_name>SHOSHTARI</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846004344</code>
	<orcid>20031947532846004344</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>S</first_name>
	<middle_name></middle_name>
	<last_name>FARJADIAN</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846004345</code>
	<orcid>20031947532846004345</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>GH</first_name>
	<middle_name></middle_name>
	<last_name>YOUSEFI-POUR </last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846004346</code>
	<orcid>20031947532846004346</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>A</first_name>
	<middle_name></middle_name>
	<last_name>AMIRZARGAR</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846004347</code>
	<orcid>20031947532846004347</orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
